This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Fluidigm Sponsors, Exhibits And Presents At Roddenberry International Symposium On Cellular Reprogramming In San Francisco

Stocks in this article: FLDM

Today’s Roddenberry International Symposium on Cellular Reprogramming in San Francisco will be Drs. Shinya Yamanaka and John Gurdon first public appearance together since being named 2012 Nobel Laureates, according to the ISSCR’s (International Society for Stem Cell Research) website. The Roddenberry International Symposium is a collaborative effort between the ISSCR and the Roddenberry Center for Stem Cell Biology and Medicine at the Gladstone Institutes.

The symposium explores the latest research on reprogramming mature cells (such as skin or fat cells) into pluripotent cells -- capable of differentiating into different types of body cells. These reprogrammed cells hold the promise of being applied in medical treatments for therapeutic gain in the future.

More than 25 of the world's top stem cell scientists -- from top global research institutions such as the National Institutes of Health, the California Institute for Regenerative Medicine, the Wellcome Trust Centre for Stem Cell Research, University of Cambridge, UCSF, Stanford, UCLA, MIT Kyoto University and Memorial Sloan-Kettering Cancer Center – have gathered to discuss recent research, advances and perspectives in cellular reprogramming.

Fluidigm Corporation is a gold sponsor of the event and is exhibiting its new C 1™ Single-Cell AutoPrep System, as well as presenting three posters on current and future applications of its integrated fluidic chip technology for single-cell analysis.

Fluidigm is a key supplier to the scientific research community investigating stem cell genomic signatures down to the single-cell level. “We are proud to provide many of these institutions with tools that allow researchers to gather genomic information at the single-cell level,” said Gajus Worthington, Fluidigm President and Chief Executive Officer.

The conference emphasizes the important role that stem cells will have in advancing life science and medical understanding, ultimately with the goal of enhancing medical practices in the future. The Rodenberry Foundation, sponsor of this symposium, sees this work as a positive, important step in bringing to reality a number of concepts for better health options.

1 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 18,053.71 +23.50 0.13%
S&P 500 2,088.77 +6.89 0.33%
NASDAQ 4,806.8590 +33.3870 0.70%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs